⌘K

Login Start Free

Home/Filings/4/0001179110-09-010094

4//SEC Filing

Laikind Paul K 4

Accession 0001179110-09-010094

CIK 0001053221other

View on SEC.gov Company Profile

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 11:44 AM ET

Size

5.5 KB

Accession

0001179110-09-010094

Insider Transaction Report

Form 4

Period: 2009-06-23

METABASIS THERAPEUTICS INCMBRX

Director

Transactions

Award
Stock Option (Right to Buy)
2009-06-23+5,000→ 5,000 total
Exercise: $0.41Exp: 2019-06-23→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]Option vests monthly over a period of one year.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

METABASIS THERAPEUTICS INC

CIK 0001053221

Entity typeother

Related Parties

1

filerCIK 0001292402

Filing Metadata

Form type: 4
Filed: Jun 24, 8:00 PM ET
Accepted: Jun 25, 11:44 AM ET
Size: 5.5 KB

View on SEC.gov